CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 265 filers reported holding CONMED CORP in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $519,680 | -25.8% | 5,153 | 0.0% | 0.07% | -26.0% |
| Q2 2023 | $700,241 | +7.6% | 5,153 | -17.8% | 0.10% | +1.1% |
| Q1 2023 | $650,891 | +164682.5% | 6,267 | +40.8% | 0.10% | +66.7% |
| Q4 2022 | $395 | -99.9% | 4,451 | +0.3% | 0.06% | -1.7% |
| Q3 2022 | $356,000 | -21.9% | 4,438 | -6.8% | 0.06% | -17.1% |
| Q2 2022 | $456,000 | -35.5% | 4,762 | 0.0% | 0.07% | -25.5% |
| Q1 2022 | $707,000 | +4.7% | 4,762 | 0.0% | 0.09% | +9.3% |
| Q4 2021 | $675,000 | +12.1% | 4,762 | +3.5% | 0.09% | -1.1% |
| Q3 2021 | $602,000 | -1.3% | 4,603 | +3.8% | 0.09% | +2.4% |
| Q2 2021 | $610,000 | -11.3% | 4,435 | -15.8% | 0.08% | -15.0% |
| Q1 2021 | $688,000 | +10.4% | 5,269 | -5.3% | 0.10% | +4.2% |
| Q4 2020 | $623,000 | +94.1% | 5,566 | +36.2% | 0.10% | +60.0% |
| Q3 2020 | $321,000 | – | 4,086 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 1,385,000 | $58,862,000 | 5.19% |
| SIGNIA CAPITAL MANAGEMENT LLC | 146,589 | $6,230,000 | 2.32% |
| HEARTLAND ADVISORS INC | 1,773,782 | $75,386,000 | 1.31% |
| NORTH TIDE CAPITAL, LLC | 350,000 | $14,875,000 | 1.30% |
| Aurora Investment Counsel | 38,196 | $1,623,000 | 1.07% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 571,150 | $24,274,000 | 0.99% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 102,500 | $4,356,000 | 0.90% |
| Tributary Capital Management, LLC | 98,862 | $4,202,000 | 0.83% |
| PERKINS CAPITAL MANAGEMENT INC | 27,850 | $1,184,000 | 0.80% |
| Iguana Healthcare Management, LLC | 25,000 | $1,063,000 | 0.61% |